Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD and simulated driving performance
ACTRN12619001552178Phase 2Completed
- Sponsor
- University of Sydney
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol, sponsored by University of Sydney. Primary endpoint: Standard deviation of lateral position. Started Dec 2019; status: completed.
02
Drugs
cannabidiol
Beyond the preview
Go deeper on ACTRN12619001552178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001552178.